Antiphospholipid antibody: future developments. - Wikidata - awgldk - TriplyDB

Antiphospholipid antibody: future developments.

Antiphospholipid antibody: future developments.

http://www.wikidata.org/entity/Q41025486

about

Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients.Cerebral microemboli in patients with antiphospholipid syndrome.

P2860

Q35673044-913ED328-9240-4201-8292-C68AAF657D38 Q40910689-FF5E9111-CA8F-45CA-AAD5-184F23E4836F

P2860

Antiphospholipid antibody: future developments.

http://www.wikidata.org/entity/Q41025486

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Antiphospholipid antibody: future developments.

@en

type

label

Antiphospholipid antibody: future developments.

@en

prefLabel

Antiphospholipid antibody: future developments.

@en

P1433

Q41025486-84CA3534-5AD9-4B21-A55E-40438B289DF9

P1476

Q41025486-95E4DBFA-1469-40E9-A7FB-D3281D4C7729

P2860

Q41025486-09A6AEC5-3AB0-472A-BF5A-CCAAEC112456

Q41025486-0C9C82EA-722C-49F2-AB68-E73091EEBE35

Q41025486-2032935F-D33F-4C7B-88C1-488024E0BF8A

Q41025486-47C4FD0C-0A45-48C5-8A78-4CDC36B7F66C

Q41025486-612DFFC7-B4FF-4D25-8BD3-D2BCF2E94C77

Q41025486-7F8DAE81-A088-41CD-BF60-2D9D30FC143C

Q41025486-95853BA6-E2B5-4B23-99A5-07FE796F1177

Q41025486-9AA50348-A2ED-459A-B529-046BBB4FB372

Q41025486-C0B0BAD9-1E7E-427C-92FD-FFED45378B9A

Q41025486-D0181101-674A-4B11-8FCC-9C3577CC6A23

P304

Q41025486-6176F579-3454-4A36-82E6-01E4B3A9DB55

P31

Q41025486-80EC7EC8-4F13-4870-B1C1-378D7E55E0A3

P356

Q41025486-30EFC822-7E37-43F1-A3F8-4A93FA502EB2

P433

Q41025486-05CE5845-7A2C-40F2-BF1A-E53872ECBA76

P478

Q41025486-0F23626E-36C7-4C8E-BA07-F24ABA7D0A1B

P50

Q41025486-516F85D4-FEEB-44A6-B898-A086DD4AEEA6

P577

Q41025486-B568E6C4-005D-46C8-B118-CA2232526DC2

P698

Q41025486-0886D254-0767-4F47-AB19-209CC49917BF

P356

096120339400300420

P1433

P1476

Antiphospholipid antibody: future developments.

@en

P2860

Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein

Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes

Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3

Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.

Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions.

Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited.

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

Antiphospholipid antibody/lupus anticoagulant workshop.

Antibodies against platelet-activating factor in patients with antiphospholipid antibodies.

Antibodies to cardiolipin in normal C57BL/6J mice: induction by estrogen but not dihydrotestosterone.

P304

309-311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/096120339400300420

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Michael D. Lockshin

P577

1994-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7804322

http://www.w3.org/2001/XMLSchema#string